Investor Type | Firm |
Type of Fund | Venture Capital Fund |
Industries | BioTech • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Life Science |
Investing | United Kingdom • Italy • Israel • Europe • Ireland |
Investment Range | $3,510,000 - $3,510,000 |
Panakes Partners is a Venture Capital firm based in Milan, Italy, specializing in investments within the health sector. It was founded in 2015 and focuses its investments in Life Sciences companies that are creating innovative solutions to important medical needs. Panakes supports entrepreneurs and scientific teams, mainly investing in ambitious early-stage startups and SMEs globally, with a particular emphasis on Europe and Israel. They aim to back promising teams by providing both financial and business support. Their investment strategy involves being an active and well-connected investor that contributes more than just capital. They work with a network of clinicians and industry experts and have established partnerships with industrial players to help accelerate the development of portfolio companies. Panakes invests in people, believing that a strong and dedicated team is a key factor in the success of an investment. Their ultimate goal is to improve lives worldwide, supporting the growth of companies that reshape the medical world by addressing real medical needs, saving lives, and improving the quality of life for patients and caregivers. The firm has a commitment to positive societal impact, which produces intrinsic value for both investors and society. Panakes' portfolio spans various domains such as dermatology, surgery, ophthalmology, cardiovascular, oncology, diagnostic, endoscopy, robotic, and neuromodulation. They also take their environmental and social responsibilities seriously, engaging in Environmental, Social, and Governance (ESG) practices, and are signatories to the UNPRI. Panakes is part of the Venture ESG community and manages funds under Article 6 SFDR, incorporating sustainability risks into their investment decision-making process. The firm maintains transparency by publishing annual ESG reports and is committed to updating their approach to managing sustainability risks.